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Burn injury differentially alters whole-blood and 
organ glutathione synthesis rates: An experimental 
model
Introduction
The tripeptide glutathione (g-glutamyl-cysteinyl-glycine; 
GSH), present in millimolar quantities in various tissues, 
plays a critical role in the detoxification of  the reactive 
electrophilic intermediates of  oxidative metabolism and 
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nitric oxide metabolism[1,2] and in redox-dependent cell 
signaling by modulating the oxidation state of  critical 
protein cysteine residues.[3,4] More recent studies revealed 
that the GSH status is directly related to the outcome of ICU 
patients,[5,6] patients with immune deficiency[7,8] and other 
diseases.[9-13] GSH status also contributes to the worsening 
of  the disease process.[14] Burn injury[15] and other critical 
illness[16] decrease the concentration of  GSH in organs and 
intracellular organelles. [17,18] In burn patients, we reported 
a reduced rate of  whole-blood GSH synthesis;[19] however, 
there is no information with which we might be able to 
judge how this latter change in burn patients might reflect 
that occurring in major organs. For investigating possible 
nutritional factors that might modulate GSH homeostasis 
A B S T R A C T
Previous studies from our laboratories revealed a reduced rate of whole-blood (WB) glutathione (GSH) synthesis in severely burned 
patients. To determine whether WB GSH metabolism is an indicator of the status of GSH metabolism in one or more of the major organs, 
we used a burn rabbit model to determine GSH concentrations and rates of synthesis in WB, liver, lungs, kidney, and skeletal muscle. 
L-[1-13C]-cysteine was infused intravenously for 6 h in rabbits at 3 days post-burn and in sham burn controls. WB and organ 13C-enrichment of 
cysteine and GSH was determined by gas chromatography/mass spectrometry. Plasma cysteine metabolic fl ux was increased signifi cantly 
(P < 0.01) following burn injury. WB, liver, and lung GSH concentrations (P = 0.054, P < 0.05, and P < 0.05, respectively) and fractional 
rates of GSH synthesis (P < 0.05, P< 0.01, and P< 0.05, respectively) were reduced at 3 days post-burn. Kidney was unaﬀ ected. There also 
appears to be an increased rate of GSH transport out of the liver after burn injury. Hence, there is a diﬀ erential impact of burn injury on 
tissue and organ GSH status, with WB qualitatively refl ecting the changes in lung and liver. It will be important to determine whether 
these changes are due to alterations in the intrinsic capacity for GSH synthesis and/or availability of amino acid precursors of GSH.
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under stressful conditions, we used an established rabbit 
model in the present study [20] to examine the effects of  burn 
injury on the concentration and synthesis rates of  reduced 
GSH in whole blood and major organs. Stable isotope tracer 
method was used to evaluate the GSH synthesis in addition 
to concentration changes in vivo. l-[13C]-cysteine was used as 
a tracer to label GSH in vivo, and a new gas chromatography/
mass spectrometric method was developed for determination 
of  the 13C-enrichment in intact GSH.[21]
Materials and methods
Animal care and induction of burn injury
Thirteen male New Zealand white rabbits of body weight 2.5-
3.0 kg purchased from Millbrook Breeding Labs (Amherst, 
MA) were used in this study. The rabbits were housed in the 
animal farm of the Massachusetts General Hospital with a 
12-h light/dark cycle and fed with regular rabbit chow (Prolab 
Hi-Fiber Rabbit, 5P25; PMI Nutrition International, Inc., 
Brentwood, MO) and water ad libitum. The composition of the 
rabbit chow is shown in Table 1. During the first 3 days, the 
animals were acclimatized to the restraint cage and the custom-
designed face mask for collection of expired air during the 
tracer study. On the fourth day, each rabbit was anesthetized 
by intramuscular injection of a mixture containing xylazine 
(5 mg/kg), ketamine (30 mg/kg), and acepromazine 
(1 mg/kg). The polyethylene catheters (PE 90 catheter with 
internal diameter of 0.034 inch and expernal diameter of  
0.050 inch (Clay Adames Co. Parsippany, NJ)) attached with 
3-cm silastic tips (ID, 0.030 in.; OD, 0.065 in.; Don Corning 
Co., Midland, NC) were implanted into the right carotid 
artery and external jugular vein, using aseptic procedures. The 
catheters were externalized via a subcutaneous tunnel at the 
interscapular area and occluded by intermittent injection caps 
(JELCO™; Critikon Inc., Tampa, FL) for later intravenous 
infusion and arterial blood sampling.
In one group, six rabbits were again anesthetized on day 5, as 
described above. The hair of the dorsum was shaved and then 
a 25% total body surface area (TBSA) third-degree burn was 
induced. The total surface area of  the rabbit was determined 
as previously described[20]; we estimated that a full-thickness 
burn surface area of  about 500 cm2 approximates to a 25% 
TBSA burn for rabbits weighing 2.5-3.0 kg. Therefore, an 
oval-shaped mark was made on the back of  the rabbits 
along a computer-generated template with total area of  500 
cm2. Then, with additional halothane inhalation to deepen 
the anesthesia, the back of  the animal was immersed into 
boiling water along the mark for 10 s. A full-thickness burn 
was later verified by histology examination. The animal 
was allowed to recover from the anesthesia with oxygen 
inhalation. Resuscitation was conducted immediately with 
a 4-h intravenous infusion of  saline (3 ml/kg, %TBSA). 
The burned area was wrapped with a sterile gauze bandage 
(Kerlix Lite®; Kendall Healthcare Products Co., Mansfield, 
MA) for protection. Another seven animals served as the 
control group. These were treated in the same manner as 
described for the burned animals, except that they received a 
sham burn injury by immersion in water at 37°C. The study 
protocol was approved by the Subcommittee on Research 
Animal Care of  the Massachusetts General Hospital.
Tracer infusion studies
The stable isotope studies were conducted on the third day 
after induction of  the thermal injury or sham burn when the 
animal was in hypermetabolic and protein catabolic state. 
Food was removed from the cage at 18:00 h on the day 
before the tracer study and the tracer infusion study started 
between 07:00 h and 08:00 h on the following day. Before 
starting the infusion, a blood sample (3 ml) was taken for 
evaluation of  baseline 13C-enrichment of  cysteine and GSH. 
Then, a primed constant infusion of  [1-13C]-cysteine tracer 
(99% abundance; MassTrace, Inc., Woburn, MA) was given 
Table 1: Composition of the rabbit diet (Prolab® Hi-Fiber Rabbit 
5P25*) 

























Total energy (kcal) 209 
*Information provided by PMI Nutrition International, Inc., PO Box 19798, Brentwood, 
MO 63144
†The unit is g, except being specifi ed
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for 6 h. The targeted infusion rate was about 1 mol/kg/min 
for the sham burn group and 0.85 mol/kg/min for the burn 
group; tracer was delivered by an accurate pump (Model 
920, Harvard Apparatus, Natick, MA), with a priming dose 
equivalent to a 60 min infusion dose, given by an intravenous 
bolus. Blood samples, 2.5 ml each, were drawn from the 
right carotid artery into 5 ml ethylenediaminetetraacetic 
acid (EDTA)-coated vacuum tubes (Vacutainer®, K
3
EDTA; 
Becton-Dickinson and Co., Franklin Lakes, NJ) at baseline 
and then at 60, 120, 180, 240, 270, 300, and 360 min after 
beginning the infusion. Aliquots of  blood samples, 50 l, 
were immediately mixed with 1 ml of  ice-cold dithiothreitol 
(DTT, 20 mM in 1 M acetic acid) and frozen at –70°C. The 
plasma was separated immediately from the whole blood 
by centrifugation at –4°C. At the end of  the infusion study, 
euthanasia was performed by intravenous injection of  an 
overdose (>100 mg/kg) of  sodium phenobarbital (Anpro 
Pharmaceutical, Arcadia, CA). The liver, lungs, kidney, 
and skeletal muscle (left quadriceps femoris) samples were 
taken immediately and frozen in liquid nitrogen. They were 
kept in a –70°C deep freezer until used for analysis (within 
30 days). A schematic detailing the tracer study protocol is 
presented in Figure 1.
Analytical methods
The procedure for analysis of whole-blood GSH concentration 
and isotopic enrichment has been described.[21] Briefly, the 
GSH derivative was monitored under negative chemical 
ionization conditions by selective ion monitoring (SIM) at 
nominal masses from m/z 477.1 to 480.1, corresponding to 
the most abundant and preponderant near-parent ion. The 
concentration of  whole-blood GSH was determined, using 
synthetic [1,2-13C
2
-glycyl]GSH[22] as an internal standard. 
The method is sensitive enough to determine tracer 
enrichments of  [13C-cysteine]-GSH with a quantitation limit 
in the range of  0.3-0.5 mol% excess. The enrichment of  
[1-13C]-cysteine in plasma was also measured as described 
earlier.[21]
For determination of  GSH and cysteine enrichments in the 
organs, about 0.3-0.5 g tissue samples were homogenized 
with 1 ml ice-cold DTT (in 1 M acetic acid) solution. The 
exact wet weight of the tissue was measured by the difference 
in tube weight before and after addition of  the sample. To 
exactly 500 ml of  homogenate, 20 ml of  the labeled GSH 
internal standard was added and the mixed sample was 
passed through an ion-exchange column. The fraction of  the 
elute containing GSH was collected. GSH concentrations 
and enrichments were measured, as for whole blood. The 
enrichment in the column eluate of  free cysteine was also 
determined, as for plasma.
Calculations
The plasma cysteine flux (Q
cys
) was calculated using 
the conventional steady-state equation.[21] Absence of  a 
statistically significant slope of  plasma cysteine enrichment 
during the period from 120 to 360 min was confirmed by 
linear regression analysis.
Whole-blood GSH kinetics
The rationale of  using stable isotope labeled precursor 
substrate (in the present case, 13C-labeled cysteine) to 
evaluate product (in the present case, GSH) synthesis rate 
is based on the steadily increased isotopic enrichment 
of  the product against time. The slope of  the product 
enrichment reflects how fast the precursor incorporates 
into the product, when the precursor enrichment is in a 
steady state. Thus, the fractional synthesis rate of  whole-
blood GSH (FSR
wb,gsh
/day) was calculated from the linear 
enrichment slope of  the labeled [1-13C]-cysteine-GSH in 
the whole blood [K; (molar ratio excess)/min] and the 
plasma precursor enrichment (Ep; molar ratio excess) of  
[1-13C]-cysteine. This general approach has been described 




= K × 1440
Ep
  (1)
The absolute rate of  GSH synthesis in the whole blood 
(ASR
wb;gsh
; mol/l/day) was calculated from the whole-










 (2)Figure 1: Protocol followed for tracer infusion studies to determine 
glutathione synthesis rates.
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Organ GSH synthesis rate
The fractional synthesis rate (FSR) of  GSH in different 
organs was calculated from the enrichment of  L-[1-
13C]-cysteine-GSH and that of  free L-[1-13C]-cysteine in 
each organ obtained at the end of  the tracer infusion. 
This approach assumes that the incorporation of  L-[1-
13C]-cysteine into the GSH pool in tissues follows single 
exponential kinetics as previously applied.[23,24] Thus,
Et = Eo (1 - e-kt), (3)
where Et is the enrichment of  [1-13C]-cysteine-GSH at time 
t (6 h), Eo is the enrichment of  precursor [1-13C]-cysteine 
in the organ free amino acid pool, and k is the fractional 
rate of  GSH synthesis. Hence, by algebraic conversion, the 
equation can be expressed as:
k = -t-1 × Ln(1 - Et
Eo
)  (4)
The absolute synthesis rate of  GSH in the organ (ASR, 
in mol/g wet tissue/day) was calculated from k × GSH 
concentration in each organ (expressed as mol/g wet tissue).
Data presentation and statistics
The results are expressed as means ± standard error of  mean 
(SEM). Statistical evaluation of  the data was performed 
using PROSTAT software (Poly Software International, 
Inc., Pearl River, NY). All data were examined for normalcy 
of  distribution before carrying out further comparison 
tests. Independent-sample t-test was used to compare the 
metabolic measurements between the sham burn and burn 
groups. For those data which did not follow a normal 
distribution, non-parametric Wilcoxon Ranking Test 
was used for comparison between these two groups. The 
probability level below 0.05 was considered significant.
Results
Body weight and cysteine kinetics
The body weights for the burn and sham burn animals are 
shown in Table 2. Burned animals lost about 0.4 kg during 
the 3 days following burn injury. Before burn injury, the 
animals food intake was (mean ± SEM) 43.0±3.0 g/kg/
day, which provided 90 kcal/kg/day and 7.1 g protein/kg/
day, including 78 mg methionine (522 mol)/kg/day and 
82 mg cystine (341 mol)/kg/day. On the first post-burn 
day, food intake was 35.0 ± 2.1 g/kg/day, but by day 2 it 
was 45.3 ± 3.2 g/kg/day.
During the last 4 h of  tracer infusion studies, plasma 
cysteine enrichment reached a plateau level, as shown in 
Figure 2. The plasma cysteine flux was about 220% higher 
in burned as compared with sham burn animals [Table  2], 
reflecting, in part, a significant increase in whole-body 
protein turnover and release of  cysteine via proteolysis.[20]
Blood GSH kinetics
The enrichment of  labeled GSH in whole blood showed 
a progressive increment during the tracer infusion period 
[Figure 2]. The calculated whole-blood FSR
wb,gsh
 in the 
burned animals was (mean ± SEM; per day) 0.38 ± 0.02 and 
significantly lower than for the sham burn controls (P < 0.05) 
[Table 2]. The blood GSH concentration showed a tendency to 
decline in the burned animals, (P = 0.054 by unpaired t-test). 
The absolute rate of whole-blood GSH synthesis (ASR
wb,gsh
) 
was significantly reduced (P < 0.01) by about 30% in burned 
animals.
Table 2: Whole-blood GSH and plasma cysteine kinetics in 
sham burn and burned rabbits
Sham burn Burned 
Body weight (kg)  2.7 ± 0.1  2.5 ± 0.1
Cysteine flux (mol/kg/h)  29.3 ± 5.1  65.6 ± 8.9†
Increment of 13C-cysteine-GSH 
enrichment (molar ratio excess/min)
 2.09 × 10−4  1.15 × 10−4†
FSRwb,gsh (per day)  0.46 ± 0.04  0.38 ± 0.02
¥
Blood GSH concentration (mol/l)  1486.0 ± 118.6  1263.8 ± 78.7§
Blood GSH synthesis rate (ASRwb,gsh, mol/min/l)
 666.7 ± 58.2  486.9 ± 41.6¶
*Data are presented as Mean±SEM, sham burn n=7, burned n=6
†Signifi cantly different from sham burn animals, P<0.001 by unpaired t-test (equal 
variance)
¥Signifi cantly different from sham burn animals, P<0.05 by unpaired t-test by Wilcox 
ranking test
§Signifi cantly different from sham burn animals, P=0.054 by unpaired t-test (equal 
variance)
¶Signifi cantly different from sham burn animals, P<0.01 by Wilcox ranking test
Figure 2: The plasma enrichment (molar ratio excess) of [13C]-cysteine 
and whole-blood [13C]-cysteine-GSH in sham burn (n = 6) and burned 
(n= 7) rabbits during the 360-min tracer infusion study.
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GSH kinetics and concentration in organs
The enrichments of L-[1-13C]-cysteine-GSH and L-[1-13C]-
cysteine in the liver, lung, and kidney of the two groups of  
animals are shown in Figure 3. The concentrations, FSR, and 
ASR of GSH in the organs are summarized in Table 3. Burn 
injury caused significant reduction in the concentration of  
GSH in the liver and lungs; the concentration was unaffected 
in the kidneys. The FSR in the liver (P = 0.058) and lungs 
(P < 0.01) decreased after burn injury, but it did not change 
in the kidneys. As a consequence, the estimated ASR of  
GSH in the liver (P < 0.01) and lungs (P < 0.05) showed 
significant decline with burn injury. The ASR for kidney GSH 
remained unchanged. We failed to determine a reliable GSH 
concentration and enrichment in skeletal muscle from burned 
animals. However, determinations were possible on muscle 
from sham burn animals, suggesting a significant burn-induced 
depletion of GSH. Specifically, the GSH concentration in 
the left quadriceps femoris muscle of sham burn animals was 
1.00± 0.37 mol/g wet weight; FSR was 2.00 ± 0.66/day and 
the ASR was 2.5 ± 1.2 mol/day/g wet weight.
Discussion
Extensive studies reported that GSH concentrations in 
the blood and tissues are decreased in multiple diseased 
conditions,[7-10] especially in burn and other critical 
illness.[15-18] From a dynamic point of  view, the reduced 
GSH level could be related to a negative balance between 
the changes of  GSH synthesis and GSH utilization. The 
present study can be considered as the first report on the 
changed dynamics of  GSH metabolism instead of  merely 
concentrations in multiple tissues/organs in response to 
burn injury. Based on the results of  the present study, it 
can be decided what further mechanistic investigations 
are required.
Using  a  stable  isotope  tracer  approach  and  gas 
chromatography/mass spectrometry technique, we have 
been able to determine the rate of  GSH synthesis in 
whole blood, lungs, liver, and kidneys in sham burn and 
burned rabbits. Our findings reveal that the reduction 
of  GSH content in the lungs, liver, muscle, and whole 
blood, 3 days after a thermal injury, is associated with 
a significant reduction in the absolute rate of  GSH 
synthesis in the liver and lungs. Since dietary GSH (up to 
100 mg/day) is taken up by enterocytes and protects 
against absorption of  peroxidized lipids with minimal 
release into the blood,[25-27] body GSH is virtually totally 
synthesized de novo in the tissues. Therefore, it can be 
concluded that a reduced GSH de novo synthesis rate 
accounts for, at least in part, the GSH depletion in 
different organs following burn injury.
Changes in GSH status in response to severe stressed 
conditions are time dependent[16] and related to the 
nature of  the stressor.[28] Ikegami[18] and K eller[29] reported 
decreased tissue GSH concentrations in rat liver during 
the first few hours of  an infection and during septic shock. 
Hunter and Grimble[30] reported increased concentrations 
of  GSH in the liver, 24 h after stimulation of  tumor 
necrosis factor or endotoxin. Malmezat et al.,[31,32] reported 
increased GSH concentrations in the liver, spleen, 
skeletal muscle, lung, and heart, but a decrease in whole 
blood, 2 days after the rats received an injection of  live 
Escherichia coli, associated with elevated activities of  liver 
g-glutamylcysteine synthetase and GSH reductase. In 
Table 3: GSH concentration, FSR, and synthesis rates in tissues after burn injury
GSH concentration (mol/g wet tissue) GSH FSR (per day) GSH synthesis rate (mol/g wet tissue/day) 
Sham burn Burned Sham burn Burned Sham burn Burned
Liver 2.00±0.17 0.61±0.05* 5.86±1.36 3.76±0.76§ 10.85±1.15 2.12±0.30¥
Lungs 1.15±0.11 0.79±0.08* 1.54±0.40 0.51±0.06* 1.65±0.32 0.40±0.05*
Kidneys 0.20±0.06 0.25±0.04 3.58±0.23 4.06±0.84 0.69±0.18 0.87±0.12
*Signifi cantly different from the sham burn group, P<0.05, by Wilcox ranking test
¥Signifi cantly different from the sham burn group, P<0.01, by Wilcox ranking test
§P=0.058, by Wilcox Ranking test
Figure 3: The enrichments (molar ratio excess) of [13C]-cysteine and 
[13C]-cysteine-GSH in different tissues in sham burn and burned rabbits 
after 360 min of tracer infusion.
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humans, at 24-72 h following surgical trauma, there is a 
decreased concentration of  GSH in the skeletal muscle 
and reduced GSH synthetase capacity. Reid et al.[33] also 
reported reduced concentrations of  erythrocyte GSH and 
lowered FSR and ASR in malnourished children at the time 
of  infection and after the infections had cleared and the 
edema subsided. The present findings of  GSH metabolism 
after burn injury in an animal model are in agreement 
with the above reports in surgical patients. Our results 
further indicated that the reduced GSH concentration 
and synthesis rates in the liver and lungs occurred at the 
hypermetabolic and catabolic state of  burn injury.[20] 
We have previously drawn some general parallels between 
the current burn-rabbit model and the findings in severely 
burned patients.[20] Thus, the reduced rate of  whole-blood 
GSH synthesis in burned patients[19] may qualitatively 
reflect changes in GSH synthesis in organs such as the 
liver and lungs, which we are unable to probe in humans 
with our current tracer techniques. Since the whole-blood 
GSH mostly reflects GSH in red blood cells,[34] the results 
of  the present study are in general agreement with the other 
reports stating that erythrocytes’ GSH synthesis reflects that 
in organs, especially the liver.[35]
De novo GSH synthesis is mainly regulated by three factors: 
1) the intracellular level and activities of  glutamate-
cysteine ligase (GCL), which catalyzes the rate-limiting 
first step of  GSH synthesis in the -glutamyl cycle;[36,37] 2) 
availability of  cysteine and other amino acid precursors, 
glutamate and glycine; and 3) feedback inhibition of  
GSH.[28]
GCL consists of  a larger catalytic subunit and a smaller 
modulator subunit. Genes for the subunit proteins are 
located on separate chromosomes. The expression 
of  GCL is regulated by multiple factors. Under the 
conditions of  severe burn injury and sepsis, impaired 
insulin function could affect liver GCL expression, as 
has been demonstrated in type II diabetes condition. The 
signals involve Phosphoinositide 3-kinase/Protein Kinase 
B/ p70S6 kinase (PI3K/Akt/p70S6K) pathway[38,39] the 
induced transforming growth factor (TGF)-1 after burn 
injury[40] may also inhibit the transcriptional activity of  
GCL subunit. Furthermore, GCL subunit can be cleaved 
by a caspase 3-dependent mechanism under increased 
apoptosis, which is seen after burn injury.[41] Based on 
the results of  the present study, further mechanistic 
studies will be directed toward the investigations on 
the molecular basis for reduced GSH synthesis in the 
g-glutamyl cycle pathways under the burn injury-induced 
severe inflammatory state.
In addition to enzyme activities, substrate availability may 
be a more important factor causing the reduction of  GSH 
synthesis in prolonged bed-resting burn patients. Since the 
clinically used parenteral nutrition solution lacks cysteine 
and the altered methionine-homocysteine cycle after burn 
injury may compromise endogenous cysteine synthesis,[42] 
these factors lead to a reduction of  cysteine availability, 
which contributes to reduced GSH synthesis in burn patients. 
Conversely, an increased cysteine supply has been shown to 
improve GSH status in other disease conditions.[7] Extensive 
literature also suggested that glutamine deficiency is related 
to reduced GSH synthesis in ICU patients,[43] although the 
most recent clinical trials questioned the beneficial effect of  
glutamine supplementation at 30 g/day in these patients.[44]
The present study revealed that the plasma cysteine flux or 
turnover rate increased by about 36 mol/kg/h, 3 days after 
burn injury. This change appears to be more dramatic than the 
increase in plasma cysteine flux reported by Malmezat et al.[32] 
In rats, 2 days after an E. coli challenge. The increased 
metabolic flux of  cysteine is contributed by the following 
factors: 1) increased proteolysis in the hypermetabolic state 
of  burn injury, which accounts for 61% of  the measured 
increment of  36 mol/kg/h [Table 2] and 2) increased 
GSH catabolism, which is supported by the finding that in 
human subjects, the breakdown of GSH (by the ectoenzyme 
g-glutamyl transpeptidase) makes a quantitatively important 
contribution to the plasma metabolic flux of  cysteine.[45] 
Malmezat et al.[32] have also suggested that the increased 
cysteine turnover in infected rats is due, in part, to increased 
GSH turnover.
In summary, the present study has revealed a significantly 
reduced rate of  GSH synthesis in whole blood, liver, 
and lungs following burn injury, which accounts for 
the reduced GSH levels in these tissues, rendering the 
tissues vulnerable to oxidative damage and impaired 
mitochondrial function.[46] The reduced GSH synthesis is 
largely related to substrate availability. GSH concentration 
and synthesis in the kidney appears to be unaffected, which 
is related to the fact that kidneys receive GSH by inward 
transport from circulation.[47] The present study directs 
further investigations on the mechanism of  this reduced 
GSH availability in organs/tissues, with emphasis on 1) 
the molecular mechanism of  the enzymatic changes in 
-glutamyl cycle, the machinery of  GSH synthesis; 2) the 
mechanism of  oxidative damage under the reduced GSH 
content in tissues; and 3) the interventions that sustain or 
stimulate GSH synthesis, using organ-directed, nutritional, 
and/or pharmacological approaches, with the ultimate 
goal of  ameliorating mortality and morbidity of  severely 
burned patients.
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Abbreviations:
ASR Absolute synthesis rate
DTT Dithiothreitol
FSR Fractional synthesis rate
GSH Glutathione
Qcys Plasma cysteine flux
SIM Selective ion monitoring
WB Whole blood
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